ABL Bio Inc.
A global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases.
64 employees · est. 2016 · Korea South
ProfoundBio
An oncology biotherapeutics company
8 employees · est. 2018 · Woodinville, United States
ABL Bio Inc. is the older company (2016 vs 2018); ABL Bio Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | ABL Bio Inc. | ProfoundBio |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2018 |
| Headquarters | ||
| Headquarters | Korea South | Woodinville, United States |
| Employees | ||
| Employees | 64 larger | 8 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | IPO | Series B |
| Total Funding | ||
| Total Funding | $49.12B | $247.00M |
| Funding Rounds | ||
| Funding Rounds | 6 | 4 |
| Services | ||
| Services | Development of innovative therapeutic drugs, Research and development of cancer and neurodegenerative disease treatments, Creating and managing biopharmaceutical platforms, Clinical trials and regulatory approval processes | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare providers, Patients with cancer and neurodegenerative diseases, Pharmaceutical companies, Medical researchers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Bispecific Antibody Therapeutics, Immuno-Oncology, Neurodegenerative Diseases, Grabody-T, Grabody-I, Grabody-B, 4-1BB Engagement, Blood-Brain Barrier Penetration, Clinical Stage Drug Candidates, Pre-Clinical Stage Drug Candidates, Antibody Drug Conjugate, CNS Targets, Strategic Partnerships, Next-Generation Antibody | Antibody-based Therapeutics, Clinical-stage, Cancer Research, ADC Drug Candidates, Solid Tumors, Hematological Malignancies, Proprietary Technology, Seattle, Cancer Treatment, Innovative Drug Development, Oncology, Targeted Therapy, Precision Medicine |
| Website | ||
| Website | ablbio.com | profoundbio.com |
About ABL Bio Inc.
ABL Bio Inc., founded in 2016 and headquartered in Korea South, stands as a prominent figure in the biotechnology space. Known for being a global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases, the company has carved out a niche in delivering innovative...
About ProfoundBio
ProfoundBio is a clinical-stage biotechnology company founded in 2018. The company is focused on developing novel antibody-based therapeutics with curative potential for patients with cancer. ProfoundBio has a pipeline of multiple antibody-drug conjugate (ADC) drug candidates targeting solid tumors...
We will tell you when either one moves
BounceWatch watches ABL Bio Inc. and ProfoundBio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ABL Bio Inc. and ProfoundBio — by email.
Frequently Asked Questions
Compare ABL Bio Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at ABL Bio Inc. on 15 Jun 2026, and ProfoundBio on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.